The funding will support a WashU Medicine collaboration with CRISPR Therapeutics and SynGenix, a WashU startup, to move a single-injection treatment to reverse joint damage into clinical trials. The post Osteoarthritis therapy study advances with $17 million from ARPA-H appeared first on The Source .